Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts

BACKGROUND: Pancreatic carcinoma remains a treatment-refractory cancer with a poor prognosis. Here, we compared anti-EGF receptor and anti-HER2 monoclonal antibodies (2mAbs) injections with standard gemcitabine treatment on human pancreatic carcinoma xenografts. MATERIALS AND METHODS: Nude mice, bea...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Larbouret, Christelle, Robert, Bruno, Bascoul-Mollevi, Caroline, Penault-Llorca, Frédérique, Ho-Pun-Cheung, Alexandre, Morisseau, Sébastien, Navarro-Teulon, Isabelle, Mach, Jean-Pierre, Pèlegrin, André, Azria, David
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3508938/
https://ncbi.nlm.nih.gov/pubmed/19889608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdp496
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia